Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU
Investing.com -- Biohaven Pharma (NYSE: BHVN) shares fell sharply by as much as 21% as the company withdrew its marketing authorization application for Dazluma in Europe, intended to treat sp...
Cantor Equity shares rally amid retail investor fervor for bitcoin
(Reuters) -Shares of blank-check firm Cantor Equity Partners surged 29% on Friday, extending a scorching rally from their previous session, as retail investors hoping to capitalize on the gro...
HCA Healthcare beats profit estimates on strong demand for medical care
(Reuters) -HCA Healthcare beat Wall Street estimates for first-quarter profit on Friday, as the hospital operator benefited from sustained demand for elective procedures in the United States....
